Defective adenoviruses and corresponding complementation lines

Details Defective adenoviruses and corresponding complementation lines Defective adenoviruses and corresponding complementation lines

2006-06-27

2006-06-27

Priebe, Scott D. (Department: 1632)

Chemistry: molecular biology and microbiology

Vector, per se

C424S093200, C435S455000, C435S456000

Reexamination Certificate

active

07067309

ABSTRACT:
Novel defective adenoviruses for the transfer and expression of an exogenous nucleotide sequence in a host cell or organism. The invention also relates to novel complementation lines and to the process for the preparation of these novel defective adenoviruses and their use in therapy and to a pharmaceutical composition containing same.

REFERENCES:
patent: 4920209 (1990-04-01), Davis et al.
patent: 5543328 (1996-08-01), McClelland et al.
patent: 5670488 (1997-09-01), Gregory et al.
patent: 5700470 (1997-12-01), Saito et al.
patent: 5756086 (1998-05-01), McClelland et al.
patent: 5981275 (1999-11-01), Armentano et al.
patent: 5994106 (1999-11-01), Kovesdi et al.
patent: 6040174 (2000-03-01), Imler et al.
patent: 6133028 (2000-10-01), Imler et al.
patent: 6204060 (2001-03-01), Mehtali et al.
patent: 6482616 (2002-11-01), Kovesdi et al.
patent: 93/06223 (1993-04-01), None
patent: 93/19191 (1993-09-01), None
patent: 94/12649 (1994-06-01), None
patent: 94/28152 (1994-12-01), None
Orkin et.al.; Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, issued by the US National Institute of Health, 1995.
Carter et al., “Adenovirus Containing a Delection of the Early Region 2A Gene Allows Growth of Adeno-Associated Virus with Decreased Efficiency,”Virology,1992, vol. 191, pp. 473-476, American Society for Microbiology, Washington, D.C.
Bridge et al., “Adenovirus Early Region 4 and Viral DNA Synthesis,”Virology,1993, vol. 193, pp. 794-801, American Society for Microbiology, Washington, D.C.
Cutt et al., “Analysis of Adenovirus Early Region 4-Encoded Polypeptides Synthesized in Productively Infected Cells,”Journal of Virology,1987, vol. 61, No. 2, pp. 543-552, American Society for Microbiology, Washington, D.C.
Bridge et al., “Redundant Control of Adenovirus Late Gene Expression by Early Region 4,”Journal of Virology,1989, vol. 63, No. 2, pp. 631-638, American Society for Microbiology, Washington, D.C.
Rice et al., “Isolation and Analysis of Adenovirus Type 5 Mutants Containing Deletions in the Gene Encoding the DNA-Binding Protein,”Journal of Virology,vol. 56, No. 2, pp. 767-778, American Society for Microbiology, Washington, D.C.
Karlsson et al., “Stable gene transfer and tissue-specific expression of a human globin gene using adenoviral vectors,”The EMBO Journal,vol. 5, No. 9, pp. 2377-2385, Oxford University Press, Oxford UK.
Graham et al., Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5,The Journal of General Virgology,1977, vol. 36, pp. 59-74, Society for General Microbiology, Spencers Wood, Reading UK.
Brough et al., “Construction, Characterization, and Utilization of Cell Lines Which Inducibly Express the Adenovirus DNA-Binding Protein,”Virology,vol. 190, pp. 624-634, American Society for Microbiology, Washington, D.C., 1992.
Graham, “Adenoviruses as expression vectors and recombinant vaccines,”Trends in Biotechnology,1990, vol. 8, pp. 85-88, Elsevier, UK.
Ginsberg et al., “A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia,”Proc. Natl. Adad. Sci. USA,1991, vol. 88, pp. 1651-1655, National Academy of Sciences, Washington, D.C.
Klinman et al., “Introduction to the Issues: Viral Vectors and Potential Problems in their Use,”Developments in Biological Standardization,vol. 76, pp. 299-300, International Union of Microbiological Societies, Karger, Basel, Switzerland.
Müllbacher et al., “The murine cellular immune response to adenovirus type 5,”Immunology Cell Biol.,1989, vol. 67, pp. 31-39, Blackwell Scientific Publications, Oxford UK.
Brunet et al., “Concentration Dependence of Transcriptional Transactivation in Inducible E1A-Containing Human Cells,”Molecular and Cellular Biology,1988, vol. 8, No. 11, pp. 4799-4807, American Society for Microbiology, Washington, D.C.
Bridge et al., “Interaction of Adenoviral E4 and E1B Products in Late Gene expression,”Virology,1990, vol. 174, pp. 345-353, American Society for Microbiology, Washington, D.C.
Horwitz, “Adenoviridae and Their Replication,”Fields Virology,second edition, vol. 2, chapter 60, pp. 1679-1721, Raven Press, Ltd., New York.
Krougliak et al.,Human Gene Therapy,6:1575-1586 (1995).
Yeh et al.,Journal of Virology,70(1):559-565 (1996).
Wang et al.,Gene Therapy,2:775-783 (1995).
Fallaux et al.,Human Gene Therapy,9:1909-1917 (1998).
Fallaux et al.,Human Gene Therapy,7:215-222 (1996).
Senear et al.,Molecular and Cellular Biology,6(4):1253-1260 (1986).
Bernards et al.,Virology,120:422-432 (1982).
Roberts et al.,Journal of Virology,56(2):404-413 (1985).
Vaessen et al.,The EMBO Journal,5(2):335-341.
Louis et al.,Virology,186:280-285 (1992).
Chrobocek et al.,Virology,186:280-285 (1992).
Berkner,Current Topics in Microbiology and Immunology,158:39-66 (1992).
Grable et al.,Journal of Virology,64(5):2047-2056.
Armentano et al.,Human Gene Therapy,6:1343-1353 (1995).
Klessing et al.,Molecular and Cellular Biology,4(7):1354-1362 (1984).
Englehardt et al.,Proc. Natl. Acad. Sci.,91:6196-6200 (1994).
Gao et al.,Journal of Virology,70(12):8934-8943 (1996).
Mastrangeli et al.,The Journal of Clinical Investigation, Inc.,91:225-234 (1993).
Rosenfeld et al.,Science,252:431-434 (1991).
Randrianarison-Jewtoukoff et al.,Biologicals,23:145-157 (1995).
Trapnell et al.,Current Opinion in Biotechnology,5:617-625 (1994).
Lusky et al.,Journal of Virology,72(3):2022-2032 (1998).
Wang et al.,Gene Therapy,4:393-400 (1997).
LaFont et al.,Lancet,346:1442-1443 (1995).
Marshall,Science,269:1050-1055 (1995).
Miller et al.,FASEBJ,9:190-199 (1995).
Culver et al.,TIG,10(5):174-178 (1994).
Hodgson,Exp. Opin. Ther. Pat.,5(5):459-468 (1995).
Berkner et al.,Biotechniques,6(7):616-628 (1988).
Weinberg et al.,Proc. Nat. Acad. Sci.,80:5383-5386 (1993).
Bajocchi et al.,Nature Genetics,3:229-234 (1993).
James et al.,Antiviral Chem. Chemo.,2(4):191-214 (1991).
Babiss,Journal of Virology,63(6):2709-2717 (1989).
Statford-Perricaudet et al.,Human Gene Transfer,219:51-61 (1991).
Rosenfeld et al.,Cell,68(1):143-155 (1992).
Imler et al.,Gene Therapy,3:75-84 (1996).
Bellon et al.,Human Gene Therapy,8:15-25 (1997).
Ketner, et al.,Nucleic Acids Research, 17(8):3037-3048(1989).
Sussenbach, editor,The Adenoviruses,“The Structure of the Genome,” Chapter 3, Plenum Press, 1984, New York, New York, pp. 35-124.

Affiliated with

Also associated with

Rating

Defective adenoviruses and corresponding complementation lines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Defective adenoviruses and corresponding complementation lines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Defective adenoviruses and corresponding complementation lines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3679475